- Home
- RCKY vs IMRX Comparison
RCKY vs IMRX Comparison
Compare RCKY & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- IMRX
- Stock Information
- Founded
- RCKY 1932
- IMRX 2008
- Country
- RCKY United States
- IMRX United States
- Employees
- RCKY N/A
- IMRX N/A
- Industry
- RCKY Shoe Manufacturing
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- IMRX Health Care
- Exchange
- RCKY Nasdaq
- IMRX Nasdaq
- Market Cap
- RCKY 174.1M
- IMRX 145.7M
- IPO Year
- RCKY 1993
- IMRX 2021
- Fundamental
- Price
- RCKY $27.83
- IMRX $3.52
- Analyst Decision
- RCKY Hold
- IMRX Strong Buy
- Analyst Count
- RCKY 1
- IMRX 4
- Target Price
- RCKY $30.00
- IMRX $13.25
- AVG Volume (30 Days)
- RCKY 68.5K
- IMRX 486.1K
- Earning Date
- RCKY 07-29-2025
- IMRX 08-19-2025
- Dividend Yield
- RCKY 2.25%
- IMRX N/A
- EPS Growth
- RCKY 24.23
- IMRX N/A
- EPS
- RCKY 2.48
- IMRX N/A
- Revenue
- RCKY $462,328,000.00
- IMRX N/A
- Revenue This Year
- RCKY $6.67
- IMRX N/A
- Revenue Next Year
- RCKY $4.25
- IMRX N/A
- P/E Ratio
- RCKY $11.14
- IMRX N/A
- Revenue Growth
- RCKY N/A
- IMRX N/A
- 52 Week Low
- RCKY $11.93
- IMRX $1.00
- 52 Week High
- RCKY $34.69
- IMRX $4.69
- Technical
- Relative Strength Index (RSI)
- RCKY 68.67
- IMRX 47.82
- Support Level
- RCKY $24.68
- IMRX $3.25
- Resistance Level
- RCKY $30.90
- IMRX $4.69
- Average True Range (ATR)
- RCKY 1.41
- IMRX 0.28
- MACD
- RCKY 0.32
- IMRX -0.13
- Stochastic Oscillator
- RCKY 63.45
- IMRX 18.76
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.